182 related articles for article (PubMed ID: 27130455)
1. A retrospective analysis to identify predictors of COPD-related rehospitalization.
Roberts MH; Clerisme-Beaty E; Kozma CM; Paris A; Slaton T; Mapel DW
BMC Pulm Med; 2016 Apr; 16(1):68. PubMed ID: 27130455
[TBL] [Abstract][Full Text] [Related]
2. Risk assessment of readmissions following an initial COPD-related hospitalization.
Baker CL; Zou KH; Su J
Int J Chron Obstruct Pulmon Dis; 2013; 8():551-9. PubMed ID: 24348031
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with inpatient readmission among managed care enrollees with COPD.
Candrilli SD; Dhamane AD; Meyers JL; Kaila S
Hosp Pract (1995); 2015; 43(4):199-207. PubMed ID: 26357878
[TBL] [Abstract][Full Text] [Related]
4. Predictors of early readmission among patients 40 to 64 years of age hospitalized for chronic obstructive pulmonary disease.
Sharif R; Parekh TM; Pierson KS; Kuo YF; Sharma G
Ann Am Thorac Soc; 2014 Jun; 11(5):685-94. PubMed ID: 24784958
[TBL] [Abstract][Full Text] [Related]
5. Clinical factors, including All Patient Refined Diagnosis Related Group severity, as predictors of early rehospitalization after COPD exacerbation.
Roberts MH; Mapel DW; Von Worley A; Beene J
Drugs Context; 2015; 4():. PubMed ID: 25834619
[TBL] [Abstract][Full Text] [Related]
6. In-hospital and one-year mortality and their predictors in patients hospitalized for first-ever chronic obstructive pulmonary disease exacerbations: a nationwide population-based study.
Ho TW; Tsai YJ; Ruan SY; Huang CT; Lai F; Yu CJ;
PLoS One; 2014; 9(12):e114866. PubMed ID: 25490399
[TBL] [Abstract][Full Text] [Related]
7. Predictors of Appropriate Pharmacotherapy Management of COPD Exacerbations and Impact on 6-Month Readmission.
Tran M; Xiang P; Rascati KL; Stock EM; Godley PJ; Coleman A; Bogart MR; Stanford RH
J Manag Care Spec Pharm; 2016 Oct; 22(10):1186-93. PubMed ID: 27668567
[TBL] [Abstract][Full Text] [Related]
8. Impact of chronic obstructive pulmonary disease on readmission after hospitalization for acute heart failure: A nationally representative US cohort study.
Gulea C; Zakeri R; Quint JK
Int J Cardiol; 2019 Sep; 290():113-118. PubMed ID: 31101544
[TBL] [Abstract][Full Text] [Related]
9. Trends in 30-day readmission rates after COPD hospitalization, 2006-2012.
Goto T; Faridi MK; Gibo K; Toh S; Hanania NA; Camargo CA; Hasegawa K
Respir Med; 2017 Sep; 130():92-97. PubMed ID: 29206640
[TBL] [Abstract][Full Text] [Related]
10. Associations between physical activity and 30-day readmission risk in chronic obstructive pulmonary disease.
Nguyen HQ; Chu L; Amy Liu IL; Lee JS; Suh D; Korotzer B; Yuen G; Desai S; Coleman KJ; Xiang AH; Gould MK
Ann Am Thorac Soc; 2014 Jun; 11(5):695-705. PubMed ID: 24713094
[TBL] [Abstract][Full Text] [Related]
11. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
[No Abstract] [Full Text] [Related]
12. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of prediction strategy and care coordination for COPD readmissions.
Bashir B; Schneider D; Naglak MC; Churilla TM; Adelsberger M
Hosp Pract (1995); 2016 Aug; 44(3):123-8. PubMed ID: 27391991
[TBL] [Abstract][Full Text] [Related]
14. Using Machine Learning to Predict Likelihood and Cause of Readmission After Hospitalization for Chronic Obstructive Pulmonary Disease Exacerbation.
Bonomo M; Hermsen MG; Kaskovich S; Hemmrich MJ; Rojas JC; Carey KA; Venable LR; Churpek MM; Press VG
Int J Chron Obstruct Pulmon Dis; 2022; 17():2701-2709. PubMed ID: 36299799
[TBL] [Abstract][Full Text] [Related]
15. Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization.
Bélanger M; Couillard S; Courteau J; Larivée P; Poder TG; Carrier N; Girard K; Vézina FA; Vanasse A
Int J Chron Obstruct Pulmon Dis; 2018; 13():3045-3054. PubMed ID: 30319252
[TBL] [Abstract][Full Text] [Related]
16. Development and Validation of a Predictive Model to Identify Individuals Likely to Have Undiagnosed Chronic Obstructive Pulmonary Disease Using an Administrative Claims Database.
Moretz C; Zhou Y; Dhamane AD; Burslem K; Saverno K; Jain G; Devercelli G; Kaila S; Ellis JJ; Hernandez G; Renda A
J Manag Care Spec Pharm; 2015 Dec; 21(12):1149-59. PubMed ID: 26679964
[TBL] [Abstract][Full Text] [Related]
17. Determining prognosis in acute exacerbation of COPD.
Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
[TBL] [Abstract][Full Text] [Related]
18. Comparative effectiveness of budesonide/formoterol combination and fluticasone/salmeterol combination among chronic obstructive pulmonary disease patients new to controller treatment: a US administrative claims database study.
Kern DM; Davis J; Williams SA; Tunceli O; Wu B; Hollis S; Strange C; Trudo F
Respir Res; 2015 Apr; 16(1):52. PubMed ID: 25899176
[TBL] [Abstract][Full Text] [Related]
19. Healthcare Resource Utilization, Exacerbations, and Readmissions Among Medicare Patients with Chronic Obstructive Pulmonary Disease After Long-Acting Muscarinic Antagonist Therapy Initiation with Soft Mist versus Dry Powder Inhalers.
Singer D; Bengtson LGS; Elliott C; Buikema AR; Franchino-Elder J
Int J Chron Obstruct Pulmon Dis; 2020; 15():3239-3250. PubMed ID: 33324047
[TBL] [Abstract][Full Text] [Related]
20. Predictors of rehospitalization and death after a severe exacerbation of COPD.
McGhan R; Radcliff T; Fish R; Sutherland ER; Welsh C; Make B
Chest; 2007 Dec; 132(6):1748-55. PubMed ID: 17890477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
